TY - JOUR AU - Mary, D. PY - 2016 DA - 2016// TI - Glioblastoma: overview of disease and treatment JO - Clin J Oncol Nurs VL - 20 ID - Mary2016 ER - TY - JOUR AU - Brandner, S. AU - Jaunmuktane, Z. PY - 2018 DA - 2018// TI - Neurological update: gliomas and other primary brain tumours in adults JO - J Neurol VL - 265 UR - https://doi.org/10.1007/s00415-017-8652-3 DO - 10.1007/s00415-017-8652-3 ID - Brandner2018 ER - TY - JOUR AU - Chen, R. AU - Smith-Cohn, M. AU - Cohen, A. L. AU - Colman, H. PY - 2017 DA - 2017// TI - Glioma subclassifications and their clinical significance JO - Neurotherapeutics. VL - 14 UR - https://doi.org/10.1007/s13311-017-0519-x DO - 10.1007/s13311-017-0519-x ID - Chen2017 ER - TY - JOUR AU - Alan, O. AU - Telli, T. A. AU - Tuylu, T. B. AU - Arikan, R. AU - Demircan, N. C. AU - Ercelep, O. PY - 2020 DA - 2020// TI - Prognostic factors in progressive high-grade glial tumors treated with systemic approach: A single center experience JO - J Oncol Pharm Pract VL - 0 ID - Alan2020 ER - TY - JOUR AU - Jiang, H. H. AU - Lin, S. PY - 2020 DA - 2020// TI - Current status and prospect in the treatment of glioblastoma JO - Zhonghua wai ke za zhi Chinese J Surg VL - 58 UR - https://doi.org/10.3760/cma.j.issn.0529-5815.2020.01.015 DO - 10.3760/cma.j.issn.0529-5815.2020.01.015 ID - Jiang2020 ER - TY - JOUR AU - Chen, R. S. -. C. M. AU - Cohen, A. L. AU - Colman, H. PY - 2015 DA - 2015// TI - Molecular profiling of gliomas: potential therapeutic implications JO - Expert Rev Anticancer Ther VL - 15 UR - https://doi.org/10.1586/14737140.2015.1062368 DO - 10.1586/14737140.2015.1062368 ID - Chen2015 ER - TY - STD TI - Zhou L, Tang H, Wang F, Chen L, Ou S, Wu T, et al. Bioinformatics analyses of significant genes, related pathways and candidate prognostic biomarkers in glioblastoma. Mol Med Rep. 2018;18(5):4185–96. https://doi.org/10.3892/mmr.2018.9411. ID - ref7 ER - TY - JOUR AU - Dragomir, M. P. AU - Kopetz, S. AU - Ajani, J. A. AU - Calin, G. A. PY - 2020 DA - 2020// TI - Non-coding RNAs in GI cancers: from cancer hallmarks to clinical utility JO - Gut. VL - 69 UR - https://doi.org/10.1136/gutjnl-2019-318279 DO - 10.1136/gutjnl-2019-318279 ID - Dragomir2020 ER - TY - JOUR AU - Grillone, K. AU - Riillo, C. AU - Scionti, F. AU - Rocca, R. AU - Tassone, P. PY - 2020 DA - 2020// TI - Non-coding RNAs in cancer: platforms and strategies for investigating the genomic “dark matter” JO - J Exp Clin Cancer Res VL - 39 UR - https://doi.org/10.1186/s13046-020-01622-x DO - 10.1186/s13046-020-01622-x ID - Grillone2020 ER - TY - JOUR AU - Liao, Y. AU - Jung, S. H. AU - Kim, T. PY - 2020 DA - 2020// TI - A-to-I RNA editing as a tuner of noncoding RNAs in cancer JO - Cancer Lett VL - 494 UR - https://doi.org/10.1016/j.canlet.2020.08.004 DO - 10.1016/j.canlet.2020.08.004 ID - Liao2020 ER - TY - JOUR AU - Costa, F. F. PY - 2010 DA - 2010// TI - Non-coding RNAs: meet thy masters JO - Bioessays. VL - 32 UR - https://doi.org/10.1002/bies.200900112 DO - 10.1002/bies.200900112 ID - Costa2010 ER - TY - JOUR AU - Choudhari, R. AU - Sedano, M. J. AU - Harrison, A. L. AU - Subramani, R. AU - Lin, K. Y. AU - Ramos, E. I. PY - 2020 DA - 2020// TI - Long noncoding RNAs in cancer: from discovery to therapeutic targets JO - Adv Clin Chem VL - 95 UR - https://doi.org/10.1016/bs.acc.2019.08.003 DO - 10.1016/bs.acc.2019.08.003 ID - Choudhari2020 ER - TY - JOUR AU - Zhang, X. -. Z. AU - Liu, H. AU - Chen, S. -. R. PY - 2020 DA - 2020// TI - Mechanisms of Long non-coding RNAs in cancers and their dynamic regulations JO - Cancers. VL - 12 UR - https://doi.org/10.3390/cancers12051245 DO - 10.3390/cancers12051245 ID - Zhang2020 ER - TY - JOUR AU - Peng, Z. AU - Liu, C. AU - Wu, M. PY - 2018 DA - 2018// TI - New insights into long noncoding RNAs and their roles in glioma JO - Mol Cancer VL - 17 UR - https://doi.org/10.1186/s12943-018-0812-2 DO - 10.1186/s12943-018-0812-2 ID - Peng2018 ER - TY - JOUR AU - Tay, Y. AU - Rinn, J. AU - Pandolfi, P. P. PY - 2014 DA - 2014// TI - The multilayered complexity of ceRNA crosstalk and competition JO - Nature. VL - 505 UR - https://doi.org/10.1038/nature12986 DO - 10.1038/nature12986 ID - Tay2014 ER - TY - JOUR AU - Chen, W. AU - Li, Q. AU - Zhang, G. AU - Wang, H. AU - Zhu, Z. AU - Chen, L. PY - 2020 DA - 2020// TI - LncRNA HOXA-AS3 promotes the malignancy of glioblastoma through regulating miR-455-5p/USP3 axis JO - J Cell Mol Med VL - 24 UR - https://doi.org/10.1111/jcmm.15788 DO - 10.1111/jcmm.15788 ID - Chen2020 ER - TY - STD TI - Yu M, Xue Y, Zheng J, Liu X, Yu H, Liu L, et al. Linc00152 promotes malignant progression of glioma stem cells by regulating miR-103a-3p/FEZF1/CDC25A pathway. Mol Cancer. 2017;16(1):110. https://doi.org/10.1186/s12943-017-0677-9. ID - ref17 ER - TY - STD TI - Sun L, Hui AM, Su Q, Vortmeyer A, Kotliarov Y, Pastorino S, et al. Neuronal and glioma-derived stem cell factor induces angiogenesis within the brain. Cancer Cell. 2006;9(4):287–300. https://doi.org/10.1016/j.ccr.2006.03.003. ID - ref18 ER - TY - STD TI - TE Gulluoglu S, Sahin M, Kuskucu A, Kaan Yaltirik C, Ture U, Kucukkaraduman B, et al. Simultaneous miRNA and mRNA Transcriptome profiling of Glioblastoma samples reveals a novel set of OncomiR candidates and their target genes. Brain Res. 2018;1700:199–210. ID - ref19 ER - TY - JOUR AU - Feng, F. AU - Wu, J. AU - Gao, Z. AU - Yu, S. AU - Cui, Y. PY - 2017 DA - 2017// TI - Screening the key microRNAs and transcription factors in prostate cancer based on microRNA functional synergistic relationships JO - Medicine (Baltimore) VL - 96 UR - https://doi.org/10.1097/MD.0000000000005679 DO - 10.1097/MD.0000000000005679 ID - Feng2017 ER - TY - JOUR AU - Zhang, J. AU - Zhou, Y. J. AU - Yu, Z. H. AU - Chen, A. X. AU - Cao, X. C. PY - 2019 DA - 2019// TI - Identification of core genes and clinical roles in pregnancy-associated breast cancer based on integrated analysis of different microarray profile datasets JO - Bioence Reports VL - 39 ID - Zhang2019 ER - TY - JOUR AU - Anders, S. AU - Huber, W. PY - 2010 DA - 2010// TI - Differential expression analysis for sequence count data JO - Genome Biol VL - 11 UR - https://doi.org/10.1186/gb-2010-11-10-r106 DO - 10.1186/gb-2010-11-10-r106 ID - Anders2010 ER - TY - STD TI - Cline MS, Smoot M, Cerami E, Kuchinsky A, Landys N, Workman C, et al. Integration of biological networks and gene expression data using Cytoscape. Nat Protoc. 2007;2(10):2366–82. https://doi.org/10.1038/nprot.2007.324. ID - ref23 ER - TY - JOUR AU - Yin, J. AU - Zeng, X. AU - Ai, Z. AU - Yu, M. AU - Yo, W. AU - Li, S. PY - 2020 DA - 2020// TI - Construction and analysis of the lncRNA-miRNA-mRNA network based on competitive endogenous RNA reveal functional lncRNAs in oral cancer JO - BMC Med Genet VL - 13 ID - Yin2020 ER - TY - JOUR AU - Mering, C. H. M. AU - Jaeggi, D. AU - Schmidt, S. AU - Bork, P. AU - Snel, B. PY - 2003 DA - 2003// TI - STRING: a database of predicted functional associations between proteins JO - Nucleic Acids Res VL - 31 UR - https://doi.org/10.1093/nar/gkg034 DO - 10.1093/nar/gkg034 ID - Mering2003 ER - TY - JOUR AU - Yi, F. AU - Sun, M. AU - Dai, G. AU - Ramani, K. PY - 2016 DA - 2016// TI - The intrinsic geometric structure of protein-protein interaction networks for protein interaction prediction JO - IEEE/ACM Trans Comput Biol Bioinform VL - 13 UR - https://doi.org/10.1109/TCBB.2015.2456876 DO - 10.1109/TCBB.2015.2456876 ID - Yi2016 ER - TY - JOUR AU - Ana, M. PY - 2017 DA - 2017// TI - María, Blanco-Prieto, João, Sousa, et al. breaching barriers in glioblastoma. Part I: molecular pathways and novel treatment approaches JO - Int J Pharm VL - 531 UR - https://doi.org/10.1016/j.ijpharm.2017.07.056 DO - 10.1016/j.ijpharm.2017.07.056 ID - Ana2017 ER - TY - JOUR AU - Taylor, O. G. AU - Brzozowski, J. S. AU - Skelding, K. A. PY - 2019 DA - 2019// TI - Glioblastoma Multiforme: an overview of emerging therapeutic targets JO - Front Oncol VL - 9 UR - https://doi.org/10.3389/fonc.2019.00963 DO - 10.3389/fonc.2019.00963 ID - Taylor2019 ER - TY - JOUR AU - Athina, K. -. S. AU - Kleita, M. AU - Andreas, S. PY - 2015 DA - 2015// TI - Long Noncoding RNAs in Digestive System Malignancies: A Novel Class of Cancer Biomarkers and Therapeutic Targets? JO - Gastroenterol Res Pract VL - 2015 ID - Athina2015 ER - TY - JOUR AU - Fatima, R. AU - Akhade, V. S. AU - Pal, D. AU - Rao, S. M. PY - 2015 DA - 2015// TI - Long noncoding RNAs in development and cancer: potential biomarkers and therapeutic targets JO - Mol Cell Ther VL - 3 UR - https://doi.org/10.1186/s40591-015-0042-6 DO - 10.1186/s40591-015-0042-6 ID - Fatima2015 ER - TY - JOUR AU - Wang, L. AU - Cho, K. B. AU - Li, Y. AU - Tao, G. AU - Guo, B. PY - 2019 DA - 2019// TI - Long noncoding RNA (lncRNA)-mediated competing endogenous RNA networks provide novel potential biomarkers and therapeutic targets for colorectal Cancer JO - Int J Mol Ences VL - 20 UR - https://doi.org/10.3390/ijms20225758 DO - 10.3390/ijms20225758 ID - Wang2019 ER - TY - JOUR AU - Cheng, B. AU - Rong, A. AU - Zhou, Q. AU - Li, W. PY - 2020 DA - 2020// TI - LncRNA LINC00662 promotes colon cancer tumor growth and metastasis by competitively binding with miR-340-5p to regulate CLDN8/IL22 co-expression and activating ERK signaling pathway JO - J Exp Clin Cancer Res VL - 39 UR - https://doi.org/10.1186/s13046-019-1510-7 DO - 10.1186/s13046-019-1510-7 ID - Cheng2020 ER - TY - JOUR AU - Zhang, H. AU - Zhu, C. AU - He, Z. AU - Chen, S. AU - Li, L. AU - Sun, C. PY - 2020 DA - 2020// TI - LncRNA PSMB8-AS1 contributes to pancreatic cancer progression via modulating miR-382-3p/STAT1/PD-L1 axis JO - J Exp Clin Cancer Res VL - 39 UR - https://doi.org/10.1186/s13046-020-01687-8 DO - 10.1186/s13046-020-01687-8 ID - Zhang2020 ER - TY - JOUR AU - Liao, K. AU - Lin, Y. AU - Gao, W. AU - Xiao, Z. AU - Guo, L. PY - 2019 DA - 2019// TI - Blocking lncRNA MALAT1/miR-199a/ZHX1 axis inhibits glioblastoma proliferation and progression JO - Mol Ther Nucleic Acids VL - 18 UR - https://doi.org/10.1016/j.omtn.2019.09.005 DO - 10.1016/j.omtn.2019.09.005 ID - Liao2019 ER - TY - STD TI - Jin M, Wang L, Zheng T, Yu J, Sheng R, Zhu H. MiR-195-3p inhibits cell proliferation in cervical cancer by targeting BCDIN3D. J Reprod Immunol. 2020;143:103211. ID - ref35 ER - TY - STD TI - Liu X, Zhou Y, Ning YE, Gu H, Tong Y, Wang N. MiR-195-5p inhibits malignant progression of cervical Cancer by targeting YAP1. Oncotargets Ther. 2020;13:931–44. https://doi.org/10.2147/OTT.S227826. ID - ref36 ER - TY - STD TI - Long Z, Wang Y. miR-195-5p Suppresses Lung Cancer Cell Proliferation, Migration, and Invasion Via FOXK1. Technol Cancer Res Treatment. 2020;19:1533033820922587. ID - ref37 ER - TY - STD TI - Cai C, Chen QB, Han ZD, Zhang YQ, He HC, Chen JH, et al. miR-195 inhibits tumor progression by targeting RPS6KB1 in human prostate Cancer. Clin Cancer Res. 2015;21(21):4922–34. https://doi.org/10.1158/1078-0432.CCR-15-0217. ID - ref38 ER - TY - STD TI - Singh R, Yadav V, Kumar S, Saini N. MicroRNA-195 inhibits proliferation, invasion and metastasis in breast cancer cells by targeting FASN, HMGCR, ACACA and CYP27B1. Sci Rep. 2015;5(1):17454. https://doi.org/10.1038/srep17454. ID - ref39 ER - TY - JOUR AU - Sadeghi, H. AU - Golalipour, M. AU - Yamchi, A. AU - Farazmandfar, T. AU - Shahbazi, M. PY - 2019 DA - 2019// TI - CDC25A pathway toward tumorigenesis: molecular targets of CDC25A in cell-cycle regulation JO - J Cell Biochem VL - 120 UR - https://doi.org/10.1002/jcb.26838 DO - 10.1002/jcb.26838 ID - Sadeghi2019 ER - TY - JOUR AU - Blomberg, I. AU - Hoffmann, I. PY - 1999 DA - 1999// TI - Ectopic expression of Cdc25A accelerates the G1/S transition and leads to premature activation of Cyclin E- and Cyclin A-dependent kinases JO - Mol Cell Biol VL - 19 UR - https://doi.org/10.1128/MCB.19.9.6183 DO - 10.1128/MCB.19.9.6183 ID - Blomberg1999 ER - TY - JOUR AU - Kabakci, Z. AU - Käppeli, S. AU - Cantù, C. AU - Jensen, L. D. AU - König, C. AU - Toggweiler, J. AU - Gentili, C. AU - Ribaudo, G. AU - Zagotto, G. AU - Basler, K. AU - Pinna, L. A. AU - Cozza, G. AU - Ferrari, S. PY - 2019 DA - 2019// TI - Pharmacophore-guided discovery of CDC25 inhibitors causing cell cycle arrest and tumor regression JO - Sci Rep VL - 9 UR - https://doi.org/10.1038/s41598-019-38579-7 DO - 10.1038/s41598-019-38579-7 ID - Kabakci2019 ER -